BioMarin Pharmaceutical
BMRN
#1374
Rank
A$20.48 B
Marketcap
$107.49
Share price
-0.19%
Change (1 day)
-24.72%
Change (1 year)

BioMarin Pharmaceutical (BMRN) - Total debt

Total debt on the balance sheet as of September 2024 : A$0.96 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's total debt is A$0.96 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

BioMarin Pharmaceutical - Total debt on balance sheet (from 1999 to 2024)

Total debt by year

Year Total debt Change
2023-12-31A$1.60 B0.1%
2022-12-31A$1.60 B6.91%
2021-12-31A$1.50 B6.32%
2020-12-31A$1.41 B15.24%
2019-12-31A$1.22 B4.06%
2018-12-31A$1.17 B-21.64%
2017-12-31A$1.50 B58.71%
2016-12-31A$0.94 B4.26%
2015-12-31A$0.90 B15.73%
2014-12-31A$0.78 B6.89%
2013-12-31A$0.73 B119.33%
2012-12-31A$0.33 B-1.36%
2011-12-31A$0.33 B-8.59%
2010-12-31A$0.37 B-32.84%
2009-12-31A$0.55 B-31.25%
2008-12-31A$0.80 B41.47%
2007-12-31A$0.56 B94.37%
2006-12-31A$0.29 B-4.5%
2005-12-31A$0.30 B-12.43%
2004-12-31A$0.34 B108.12%
2003-12-31A$0.16 B
2001-12-31A$10.87 M7228.28%
2000-12-31A$0.14 M-12.12%
1999-12-31A$0.16 M3.43%
1998-12-31A$0.16 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
A$54.76 M-94.35%๐Ÿ‡บ๐Ÿ‡ธ USA
A$44.55 M-95.40%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.43 B-55.37%๐Ÿ‡บ๐Ÿ‡ธ USA
A$40.91 B 4,124.53%๐Ÿ‡ซ๐Ÿ‡ท France
A$0.71 B-26.22%๐Ÿ‡บ๐Ÿ‡ธ USA
A$5.27 M-99.46%๐Ÿ‡บ๐Ÿ‡ธ USA